Skip to main content
    C

    Collegium Pharmaceutical Inc (COLL)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $25.43
    +0.11 (+0.43%)

    Market Cap: $786.83M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Collegium Pharmaceutical Inc (COLL) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Collegium Pharmaceutical are Amphastar (AMPH), Pacira BioSciences (PCRX) and Ironwood Pharmaceuticals (IRWD). Collegium Pharmaceutical trades at 3.7x earnings, against a median of 10.7x for the 11 of these companies with a P/E. By market cap, Collegium Pharmaceutical ranks 11th of the 13 companies on this page; Perrigo Company (PRGO) is the largest at $2.25B.

    Peer Comparison

    COLL's ROIC of 8.1% is above the peer median of 7.9%, and its revenue growth of 3.3% is below the median of 9.8%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Collegium Pharmaceutical (COLL)$786.83M3.7x1.0x4.7%8.1%3.3%0.00%
    Amphastar P (AMPH)$1.25B10.3x1.7x13.3%7.9%8.2%0.00%
    Pacira BioSciences, Inc. (PCRX)$1.46B20.0x2.0x5.1%4.2%-1.6%0.00%
    Ironwood Pharmaceuticals Inc (IRWD)$799.61M5.4x2.0x37.4%70.5%9.0%0.00%
    Supernus Pharmaceuticals, Inc. (SUPN)$1.52B12.7x2.0x32.8%N/A13.4%0.00%
    BioCryst Pharmaceuticals Inc (BCRX)$1.96B4.4x2.0x-37.4%24937.1%13.1%0.00%
    Phibro Animal Health Corporation (PAHC)$1.46B10.7x0.9x6.7%11.7%6.3%1.37%
    Eton Pharmaceuticals Inc (ETON)$1.84B36.7x13.0x35.3%37.0%157.9%0.00%
    Cronos Group Inc (CRON)$1.24B28.4x5.6x28.0%N/A74.6%0.00%
    Kamada (KMDA)$467.05M18.9x2.4x12.7%N/A10.7%2.10%
    Evotec SE ADR (EVO)$561.51MN/A0.7x-25.2%-15.1%0.6%0.00%
    Prestige Brand Holdings Inc (PBH)$2.19B10.7x2.0x13.3%5.0%22.7%0.00%
    Perrigo Company PLC (PRGO)$2.25B7.0x0.6x-43.3%-26.3%-5.2%7.17%
    Peer median$1.46B10.7x2.0x13.0%7.9%9.8%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Collegium Pharmaceutical, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - Specialty & Generic.

    CompanyAboutPeers
    Amphastar P (AMPH)
    Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation...
    AMPH competitors
    Pacira BioSciences, Inc. (PCRX)
    Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare professionals and their patients in the United...
    PCRX competitors
    Ironwood Pharmaceuticals Inc (IRWD)
    Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products.
    IRWD competitors
    Supernus Pharmaceuticals, Inc. (SUPN)
    Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of diseases...
    SUPN competitors
    BioCryst Pharmaceuticals Inc (BCRX)
    BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.
    BCRX competitors
    Phibro Animal Health Corporation (PAHC)
    Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily...
    PAHC competitors
    Eton Pharmaceuticals Inc (ETON)
    Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases.
    ETON competitors
    Cronos Group Inc (CRON)
    Cronos Group Inc. is a cannabinoid company. The company is headquartered in Toronto, Canada.
    CRON competitors
    Kamada (KMDA)
    Kamada Ltd. develops, produces and markets plasma-derived protein therapies for orphan indications. The company is headquartered in Rehovot, Israel.
    KMDA competitors
    Evotec SE ADR (EVO)
    Evotec SE is a prominent global biotechnology company headquartered in Hamburg, Germany...
    EVO competitors
    Prestige Brand Holdings Inc (PBH)
    Prestige Consumer Healthcare Inc., develops, manufactures, markets, distributes and sells over-the-counter (OTC) healthcare products in the United States...
    PBH competitors
    Perrigo Company PLC (PRGO)
    Perrigo Company plc is an American Irish registered manufacturer of private label over-the-counter pharmaceuticals.
    PRGO competitors

    Frequently Asked Questions About COLL

    Who are Collegium Pharmaceutical's main competitors?

    The companies most similar to Collegium Pharmaceutical include Amphastar (AMPH), Pacira BioSciences (PCRX), Ironwood Pharmaceuticals (IRWD), Supernus Pharmaceuticals (SUPN) and BioCryst Pharmaceuticals (BCRX), listed from the closest match.

    Who is Collegium Pharmaceutical's biggest competitor?

    Perrigo Company (PRGO) is the largest of the similar companies at $2.25B; Amphastar (AMPH) is the closest match by business profile, size, sector and industry.

    How does COLL stock compare with its competitors?

    COLL's P/E is 3.7x against a peer median of 10.7x; its P/S is 1.0x against a peer median of 2.0x; its net margin is 4.7% against a peer median of 13.0%.

    Which of Collegium Pharmaceutical's competitors pays a higher dividend?

    Collegium Pharmaceutical pays no dividend. Perrigo Company (PRGO), Kamada (KMDA) and Phibro Animal Health (PAHC) have higher forward dividend yields; Perrigo Company (PRGO) has the highest at 7.17%.

    Is Collegium Pharmaceutical bigger than its competitors?

    No. Collegium Pharmaceutical is 11th by market cap among the 13 companies on this page; the largest is Perrigo Company (PRGO) at $2.25B.